Literature DB >> 7169970

Histopathological studies of reactions in mice injected with aluminum-adsorbed tetanus toxoid.

N Goto, K Akama.   

Abstract

Histopathological observations of changes at the injection site in mice were made for 20 weeks after a single intramuscular (im) injection of aluminum hydroxide-adsorbed tetanus toxoid (Alum-TT), plain tetanus toxoid (TT), or aluminum adjuvant (Alum alone). Marked injury to muscle fibers and infiltration of neutrophils around the aluminum remnants were observed, and some microabscesses were occasionally formed, after im injection of Alum-TT. Some mature alum-granulomas were seen in the Alum-TT group, while the Alum alone group had only a few immature alum-granulomas. The TT group showed only slight injury to muscle fibers and acute inflammation at an early stage. In the Alum-TT group, well-developed lymphold tissues and granulomatous lesions were still observable even 20 weeks after the injection; however, these changes had already diminished in the Alum alone group by that time. These findings could serve as good models for undesirable local reactions to aluminum-adjuvanted vaccines.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7169970     DOI: 10.1111/j.1348-0421.1982.tb00261.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  18 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

Review 2.  A rational, systematic approach for the development of vaccine formulations.

Authors:  Garry L Morefield
Journal:  AAPS J       Date:  2011-02-23       Impact factor: 4.009

3.  Negatively Charged Carbon Nanohorn Supported Cationic Liposome Nanoparticles: A Novel Delivery Vehicle for Anti-Nicotine Vaccine.

Authors:  Hong Zheng; Yun Hu; Wei Huang; Sabina de Villiers; Paul Pentel; Jianfei Zhang; Harry Dorn; Marion Ehrich; Chenming Zhang
Journal:  J Biomed Nanotechnol       Date:  2015-12       Impact factor: 4.099

4.  [Tetanus vaccination--tolerance and prevention of side effects].

Authors:  G Korger; U Quast; G Dechert
Journal:  Klin Wochenschr       Date:  1986-09-01

5.  Alum as an adjuvant for nanoparticle based vaccines: A case study with a hybrid nanoparticle-based nicotine vaccine.

Authors:  Yun Hu; Daniel Smith; Zongmin Zhao; Theresa Harmon; Paul R Pentel; Marion Ehrich; Chenming Zhang
Journal:  Nanomedicine       Date:  2019-06-10       Impact factor: 5.307

6.  Local histopathological reactions to aluminum-adsorbed tetanus toxoid.

Authors:  N Goto; K Akama
Journal:  Naturwissenschaften       Date:  1984-08

Review 7.  Adjuvanted influenza vaccines.

Authors:  John S Tregoning; Ryan F Russell; Ekaterina Kinnear
Journal:  Hum Vaccin Immunother       Date:  2018-01-25       Impact factor: 3.452

8.  Accumulation of plasma cells in inflamed sites: effects of antigen, nonspecific microbial activators, and chronic inflammation.

Authors:  S M Mallison; J P Smith; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

9.  Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants.

Authors:  Bassel Akache; Felicity C Stark; Umar Iqbal; Wangxue Chen; Yimei Jia; Lakshmi Krishnan; Michael J McCluskie
Journal:  Hum Vaccin Immunother       Date:  2018-01-30       Impact factor: 3.452

10.  Molecular and cellular signatures of human vaccine adjuvants.

Authors:  F Mosca; E Tritto; A Muzzi; E Monaci; F Bagnoli; C Iavarone; D O'Hagan; R Rappuoli; E De Gregorio
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.